Autoimmune Diseases  >>  Cimzia (certolizumab pegol)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cimzia (certolizumab pegol) / Astellas, UCB
NCT02430909 / 2014-003307-30: Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis

Checkmark From combination trial with bimekizumab
Jun 2019 - Jun 2019: From combination trial with bimekizumab
Completed
2
159
Europe, RoW
Bimekizumab, Certolizumab Pegol, Placebo
UCB Celltech, PRA Health Sciences
Rheumatoid Arthritis
04/17
04/17
RICE, NCT02293590: Remission by Intra-articular Injection Plus CErtolizumab

Completed
2
43
Europe
Certolizumab Pegol, Cimcia, Methoject, Lederlon, Leflunomid Gebro, Salazopyrin EN, Spiricort, Xyloneural
Rüdiger B. Müller, UCB Pharma
Rheumatoid Arthritis
12/17
01/18

Download Options